Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Short-term Intensive De-escalation Therapeutic Strategy on Long-term Regimen Simplification in Poorly Controlled Type 2 Diabetes: a National Multicenter, Prospective, Randomized Trial

NCT03958591 is registered in ClinicalTrials.gov with Yanbing Li as lead sponsor.

NCT NCT03958591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Short-term Intensive De-escalation Therapeutic Strategy on Long-term Regimen Simplification in Poorly Controlled Type 2 Diabetes: a National Multicenter, Prospective, Randomized Trial
Lead sponsor
Yanbing Li
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2019
Completion date
March 31, 2026
Enrollment
276 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type2